South Korea · Delayed Price · Currency is KRW Psomagen Statistics
Total Valuation
Psomagen has a market cap or net worth of KRW 49.82 billion. The enterprise value is 48.77 billion.
| Market Cap | 49.82B |
| Enterprise Value | 48.77B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Psomagen has 19.24 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.24M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | +26.61% |
| Owned by Insiders (%) | 2.20% |
| Owned by Institutions (%) | n/a |
| Float | 8.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.80 |
| EV / EBITDA | 13.11 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.57.
| Current Ratio | 1.59 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 3.82 |
| Debt / FCF | -24.33 |
| Interest Coverage | -1.17 |
Financial Efficiency
Return on equity (ROE) is -10.39% and return on invested capital (ROIC) is -1.69%.
| Return on Equity (ROE) | -10.39% |
| Return on Assets (ROA) | -1.29% |
| Return on Invested Capital (ROIC) | -1.69% |
| Return on Capital Employed (ROCE) | -3.24% |
| Weighted Average Cost of Capital (WACC) | 3.50% |
| Revenue Per Employee | 714.14M |
| Profits Per Employee | -18.68M |
| Employee Count | 85 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 7.27 |
Taxes
In the past 12 months, Psomagen has paid 7.65 million in taxes.
| Income Tax | 7.65M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.75% in the last 52 weeks. The beta is -0.23, so Psomagen's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | -39.75% |
| 50-Day Moving Average | 3,167.60 |
| 200-Day Moving Average | 3,538.15 |
| Relative Strength Index (RSI) | 23.82 |
| Average Volume (20 Days) | 28,712 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Psomagen had revenue of KRW 60.70 billion and -1.59 billion in losses. Loss per share was -79.24.
| Revenue | 60.70B |
| Gross Profit | 15.52B |
| Operating Income | -1.14B |
| Pretax Income | -2.84B |
| Net Income | -1.59B |
| EBITDA | 3.94B |
| EBIT | -1.14B |
| Loss Per Share | -79.24 |
Balance Sheet
The company has 14.17 billion in cash and 15.05 billion in debt, with a net cash position of -883.74 million or -45.94 per share.
| Cash & Cash Equivalents | 14.17B |
| Total Debt | 15.05B |
| Net Cash | -883.74M |
| Net Cash Per Share | -45.94 |
| Equity (Book Value) | 26.54B |
| Book Value Per Share | 1,196.06 |
| Working Capital | 10.91B |
Cash Flow
In the last 12 months, operating cash flow was -474.11 million and capital expenditures -144.68 million, giving a free cash flow of -618.79 million.
| Operating Cash Flow | -474.11M |
| Capital Expenditures | -144.68M |
| Depreciation & Amortization | 5.08B |
| Net Borrowing | 640.81M |
| Free Cash Flow | -618.79M |
| FCF Per Share | -32.17 |
Margins
Gross margin is 25.57%, with operating and profit margins of -1.88% and -2.62%.
| Gross Margin | 25.57% |
| Operating Margin | -1.88% |
| Pretax Margin | -4.68% |
| Profit Margin | -2.62% |
| EBITDA Margin | 6.49% |
| EBIT Margin | -1.88% |
| FCF Margin | n/a |
Dividends & Yields
Psomagen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.24% |
| Shareholder Yield | -0.24% |
| Earnings Yield | -3.19% |
| FCF Yield | -1.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Psomagen has an Altman Z-Score of 0.42 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 4 |